Incannex Healthcare Announces Press Release Availability - IXHL News | RalliesIncannex Healthcare Announces Press Release Availability
I
IXHL• New release on DReAMzz Phase 2 trial
- Incannex posted a new release: screening has started in the DReAMzz Phase 2 dose-confirmation trial of IHL-42X for obstructive sleep apnea.
- IHL-42X holds FDA Fast Track status; results are intended to support planned Phase 3 development.
- Prior Phase 2 data showed up to 83% reduction in AHI, with improvements in patient-reported outcomes.
ACNB
•
